Current Report Filing (8-k)
July 15 2020 - 4:55PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 9, 2020
Blox, Inc.
(Exact Name of Registrant as Specified in Charter)
Nevada
|
|
000-53565
|
|
20-8530914
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
5th Floor, 1177 Avenue of Americas,
New York, NY 10036
(Address of Principal Executive Offices) (Zip
Code)
(604)-314-9293
Registrant’s telephone number, including
area code
(Former Name or Former Address
if Changed Since Last Report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Common Shares
|
|
BLXX
|
|
OTC US
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.01. Notice of Delisting
or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;
On July 9, 2020, Blox, Inc. (“we”, “us”,
“our”, the “Company”) received notice from OTC Markets Group that the closing bid price of our common shares
has closed below $0.01 for more than 30 consecutive calendar days and no longer meets the Standards for Continued Eligibility for
the OTCQB quotation tier as per the OTCQB Standards Section 2.3(2), which states that the company must “maintain proprietary
priced quotations published by a Market Maker in OTC Link with a minimum closing bid price of $0.01 per share on at least one of
the prior thirty consecutive calendar days.”
As per Section 4.1 of the OTCQB Standards, the company will be granted
a cure period of 90 calendar days during which the minimum closing bid price for the Company’s common stock must be $0.01
or greater for ten consecutive trading days in order to continue trading on the OTCQB marketplace. If the requirement is not met
by October 7, 2020, the Company will be removed from the OTCQB marketplace and demoted to the OTC Pink reporting tier. In addition,
if the Company’s closing bid price falls below $0.001 at any time for five consecutive trading days, the Company will be
immediately removed from the OTCQB and demoted to the OTC Pink reporting tier.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: July 15, 2020
Blox, Inc.
/s/ Ronald Renee
|
|
Ronald Renne
|
|
Chairman
|
|
Biox (CE) (USOTC:BLXX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biox (CE) (USOTC:BLXX)
Historical Stock Chart
From Apr 2023 to Apr 2024